Insider · CIK 0001714105

Desikan Nithya

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001714105

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-08-31	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+25K sh	$6.88	+$172K	68,602
2020-08-31	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Commercial Officer	SSale	−25K sh	$30.00	−$750K	43,602
2020-08-31	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−25K sh	—	—	97,961
2020-08-11	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+14.5K sh	$6.88	+$100K	43,602
2020-08-11	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−14.5K sh	—	—	122,961
2020-06-30	RYTMRHYTHM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+25K sh	—	—	25,000
2020-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+80K sh	—	—	80,000
2019-12-27	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+35.2K sh	$6.88	+$242K	64,249
2019-12-27	RYTMRHYTHM PHARMACEUTICALS, INC.S Sale	Chief Commercial Officer	SSale	−35.2K sh	$22.79	−$802K	29,068
2019-12-27	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−35.2K sh	—	—	137,495
2019-08-12	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+14.5K sh	$6.88	+$100K	29,068
2019-08-12	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−14.5K sh	—	—	172,676
2019-02-13	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+70K sh	—	—	70,000
2018-08-10	RYTMRHYTHM PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+14.5K sh	$6.88	+$100K	14,534
2018-08-10	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−14.5K sh	—	—	187,210
2018-02-14	RYTMRHYTHM PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+61K sh	—	—	61,000

Recent filings

Accepted (ET)
Sep 14
Desikan Nithya0001104659-20-101370
SEC(opens sec.gov)
Aug 134
Desikan Nithya0001104659-20-094656
SEC(opens sec.gov)
Jul 24
Desikan Nithya0001104659-20-080535
SEC(opens sec.gov)
Feb 194
Desikan Nithya0001104659-20-022830
SEC(opens sec.gov)
Dec 314
Desikan Nithya0001104659-19-077301
SEC(opens sec.gov)
Aug 134
Desikan Nithya0001104659-19-045574
SEC(opens sec.gov)
Feb 154
Desikan Nithya0001104659-19-009042
SEC(opens sec.gov)
Aug 144
Desikan Nithya0001104659-18-051945
SEC(opens sec.gov)
Feb 164
Desikan Nithya0001104659-18-010367
SEC(opens sec.gov)

Companies

RHYTHM PHARMACEUTICALS, INC.Chief Commercial OfficerRYTM

Address

500 BOYLSTON STREET, 11TH FLOOR

BOSTON, MA, 02116